Product Information
METHYLPHENIDATE ER 60 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $5.8406 per EA under NDC 00591390219. Its NADAC has been published 105 times since Apr 17, 2024.
FDA first approved this application on Dec 13, 2018. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591390219
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
4/23/2025
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208861FDA Approved
12/13/2018
TE Code
AB3
On Market Since
9/30/2020
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER 60 MG CAP has been published 105 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.8406 per EA |
|---|---|
| All-time high | $5.8406 (Apr 15, 2026) |
| All-time low | $4.2068 (Aug 21, 2024) |
| 52-week high | $5.8406 |
| 52-week low | $5.8406 |
| Median price | $5.7290 |
| Average price | $5.4138 |
| Largest weekly change | -18.1% (Jul 17, 2024) |
| Weeks tracked | 105 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
+1.9%
Last surveyed Apr 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 70% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER 60 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 60 MG CAP, manufactured by Actavis Pharma, Inc., is $5.8406 per EA (NDC 00591390219), effective Apr 15, 2026.
How has the price of METHYLPHENIDATE ER 60 MG CAP changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER 60 MG CAP has held within roughly two percent of its current level. It has been tracked across 105 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 60 MG CAP?
Since Apr 17, 2024, the NADAC for METHYLPHENIDATE ER 60 MG CAP has ranged from a low of $4.2068 (Aug 21, 2024) to a high of $5.8406 (Apr 15, 2026), with a median of $5.7290 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER 60 MG CAP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE CD 60 MG CAP, is $1.7655 per EA — about 70% below METHYLPHENIDATE ER 60 MG CAP.
Who manufactures METHYLPHENIDATE ER 60 MG CAP?
METHYLPHENIDATE ER 60 MG CAP (NDC 00591390219) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.